Salivary MicroRNA Can Help Identify Risk of Concussion in Children

by Julia Samuel on  November 21, 2017 at 1:14 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Detecting microRNAs in the saliva of children and young adults with mild traumatic brain injury appear to better identify people with prolonged concussion symptoms than a standard survey of reported symptoms.
Salivary MicroRNA Can Help Identify Risk of Concussion in Children
Salivary MicroRNA Can Help Identify Risk of Concussion in Children

Concussion symptoms typically go away within 2 weeks but some children can have prolonged symptoms. An objective test to identify children at risk of prolonged symptoms would help children and their parents know what to expect. Prior research has suggested that concentrations of microRNAs, small noncoding molecules found throughout the body, change in response to traumatic brain injury.

Show Full Article


A study was done in children and young adults to compare the methods effective in detecting traumatic brain injury. Fifty-two children and young adults (average age 14) with mild traumatic brain injury mostly from sports or car accidents split into two groups: 30 with prolonged symptoms and 22 with acute symptoms.

Salivary microRNA levels when patients first sought medical care; concussion symptoms surveyed two and four weeks after head injury.

This is an observational study. Because researchers are not intervening for purposes of the study they cannot control natural differences that could explain study findings.

Concentrations of five microRNAs in saliva appeared to more accurately identify the children and young adults with prolonged concussion symptoms than a survey that measured symptoms.

Study Limitations: This is a small study of 52 patients; validation of the accuracy of microRNAs in a larger study group is needed. Future studies should examine microRNAs alongside neuroimaging and functional measures such as balance and processing speed.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive